Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
215.00
0.9 (0.42%)
BSENSE

Jun 09, 03:30 PM

BSE+NSE Vol: 10000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Mar'26
Mar'25
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Mar 2026 is 45.39%

stock-summary

Standalone Net Profit

Growth in half year ended Mar 2026 is 205.22%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Mar 2026 is 89.12%

stock-summary

Interest

Growth in half year ended Mar 2026 is 295.45%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Mar 2026 has improved from Mar 2025

Compare Half Yearly Results Of Speciality Medi. With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
44.78
19.54
25.24
129.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
44.78
19.54
25.24
129.17%
Raw Material Cost
0.00
15.24
-15.24
-100.00%
Purchase of Finished goods
42.94
0.00
42.94
(Increase) / Decrease In Stocks
-10.19
-0.71
-9.48
-1,335.21%
Employee Cost
0.96
0.69
0.27
39.13%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2.73
0.76
1.97
259.21%
Total Expenditure (Excl Depreciation)
36.44
15.98
20.46
128.04%
Operating Profit (PBDIT) excl Other Income
8.34
3.56
4.78
134.27%
Other Income
0.70
0.11
0.59
536.36%
Operating Profit (PBDIT)
9.04
3.67
5.37
146.32%
Interest
0.87
0.27
0.60
222.22%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8.17
3.40
4.77
140.29%
Depreciation
0.08
0.10
-0.02
-20.00%
Profit Before Tax
8.10
3.30
4.80
145.45%
Tax
-0.08
0.61
-0.69
-113.11%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
8.18
2.69
5.49
204.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
8.18
2.69
5.49
204.09%
Equity Capital
8.79
7.24
1.55
21.41%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.31
3.72
5.59
150.27%
Diluted Earnings per share
12.54
4.53
8.01
176.82%
Operating Profit Margin (Excl OI)
18.62%
18.22%
0.00
0.40%
Gross Profit Margin
18.24%
17.40%
0.00
0.84%
PAT Margin
18.27%
13.77%
0.00
4.50%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 44.78 Cr
in Mar 2026

Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 8.18 Cr
in Mar 2026

Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.34 Cr
in Mar 2026

Figures in Cr
Half Yearly - Interest
Interest 0.87 Cr
in Mar 2026

Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.62%
in Mar 2026

Figures in %